Hamel Associates, Inc. Abbott Laboratories Transaction History
Hamel Associates, Inc.
- $315 Million
- Q2 2024
A detailed history of Hamel Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Hamel Associates, Inc. holds 14,617 shares of ABT stock, worth $1.63 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
14,617
Previous 17,213
15.08%
Holding current value
$1.63 Million
Previous $1.96 Million
22.39%
% of portfolio
0.48%
Previous 0.63%
Shares
21 transactions
Others Institutions Holding ABT
# of Institutions
3,124Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.5 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.29 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.38 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $195B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...